Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.

Abedin S, Martens MJ, Bolaños-Meade J, Al Malki MM, Lian Q, Runaas L, Elmariah H, Gooptu M, Larkin KT, Shaffer BC, Loren AW, Solh M, Alousi AM, Jamy OH, Perales MA, Rezvani A, Bhatt A, El Jurdi N, Yao JM, Applegate K, Kean LS, Efebera YA, Reshef R, Clark W, Leifer E, Saber W, Horowitz MM, Jones RJ, Holtan SG, Hamadani M

Open source

DOI
10.1182/bloodadvances.2025015964
Published
2025 Jul 22
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025015964,
  title = {Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.},
  author = {Abedin S and Martens MJ and Bolaños-Meade J and Al Malki MM and Lian Q and Runaas L and Elmariah H and Gooptu M and Larkin KT and Shaffer BC and Loren AW and Solh M and Alousi AM and Jamy OH and Perales MA and Rezvani A and Bhatt A and El Jurdi N and Yao JM and Applegate K and Kean LS and Efebera YA and Reshef R and Clark W and Leifer E and Saber W and Horowitz MM and Jones RJ and Holtan SG and Hamadani M},
  year = {2025},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025015964},
  url = {https://doi.org/10.1182/bloodadvances.2025015964}
}

RIS

TY  - JOUR
TI  - Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
AU  - Abedin S
AU  - Martens MJ
AU  - Bolaños-Meade J
AU  - Al Malki MM
AU  - Lian Q
AU  - Runaas L
AU  - Elmariah H
AU  - Gooptu M
AU  - Larkin KT
AU  - Shaffer BC
AU  - Loren AW
AU  - Solh M
AU  - Alousi AM
AU  - Jamy OH
AU  - Perales MA
AU  - Rezvani A
AU  - Bhatt A
AU  - El Jurdi N
AU  - Yao JM
AU  - Applegate K
AU  - Kean LS
AU  - Efebera YA
AU  - Reshef R
AU  - Clark W
AU  - Leifer E
AU  - Saber W
AU  - Horowitz MM
AU  - Jones RJ
AU  - Holtan SG
AU  - Hamadani M
PY  - 2025
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025015964
UR  - https://doi.org/10.1182/bloodadvances.2025015964
ER  - 

APA

S, A., MJ, M., J, B., MM, A. M., Q, L., L, R., H, E., M, G., KT, L., BC, S., AW, L., M, S., AM, A., OH, J., MA, P., A, R., A, B., N, E. J., JM, Y., K, A., LS, K., YA, E., R, R., W, C., E, L., W, S., MM, H., RJ, J., SG, H., & M, H. (2025). Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.. Blood advances. https://doi.org/10.1182/bloodadvances.2025015964

Source records